Dexamethasone in severe COVID-19 infection: A case series

Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.

Detalles Bibliográficos
Autores principales: Hassan, Mohamed Eliwa, Hasan, Hasan MSN., Sridharan, Kannan, Elkady, Adel, ElSeirafi, Mohamed MA.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452843/
https://www.ncbi.nlm.nih.gov/pubmed/32874905
http://dx.doi.org/10.1016/j.rmcr.2020.101205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452843/
https://www.ncbi.nlm.nih.gov/pubmed/32874905
http://dx.doi.org/10.1016/j.rmcr.2020.101205

Ejemplares similares